News | April 28, 2026
From losses to lift-off: Astec gains ground in Q4 FY26
The company reported consolidated total income of Rs. 161.3 crore in Q4 FY26, a strong jump from Rs. 120.3 crore in the same period last year
The company reported consolidated total income of Rs. 161.3 crore in Q4 FY26, a strong jump from Rs. 120.3 crore in the same period last year
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
Targets high-growth eye care expansion push
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
